Cover Image
Market Research Report
Product code 
1015844

LAMEA Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027

Published: | KBV Research | 80 Pages | Delivery time: 1-2 business days

Price

Back to Top
LAMEA Erythropoietin Drugs Market By Drug Class, By Product, By Application, By Country, Growth Potential, Industry Analysis Report and Forecast, 2021 - 2027
Published: June 15, 2021
KBV Research
Content info: 80 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The Latin America, Middle East and Africa Erythropoietin Drugs Market would witness market growth of 12.8% CAGR during the forecast period (2021-2027).

Erythropoietin (EPO) is considered as a hormone produced in trace amounts by the kidneys. It circulates through the blood and stimulates the production of red blood cells in the bone marrow. This hormone promotes the division and differentiation of erythroid progenitors that produce red blood cells in the bone marrow.

The use of hemopoietic growth factors erythropoietin (EPO) mainly in the developed countries is high. However, its demand is continuously increasing in developing countries also. These drugs are used in the treatment and management of anaemia resulted in a significant decrease in the need for allogeneic blood transfusion. A large number of anaemic patients are currently treated with erythropoietin. The use of erythropoietin drugs in the treatment of anaemia in sub-Saharan Africa (SSA) is not very high.

There are cost-related challenges added burden by the most African government due to this their citizen is not able to get quality health services compared to other developed countries. Due to the presence of sub-optimal health infrastructure and low annual per capita health care expenditures, it is expected that the demand for high-cost hemopoietic drugs will grow at a slower pace in the African region during the forecast period.

Erythropoietin drugs are getting faster approvals and this gives pharmaceutical & biotechnology firms lucrative opportunities to increase the production of the drug. The government of various countries is focused on investing more in R&D and manufacturing these drugs. This is acting as the major factor propelling the market growth. Patent expiration of these unique and hard drugs is the factor helping the erythropoietin drug market to grow further. The patent expiration of these biologics in the coming years is likely to create more opportunities for players to enter the erythropoietin market.

The Biologics market dominated the Saudi Arabia Erythropoietin Drugs Market by Drug Class in 2020, thereby, achieving a market value of $56.9 million by 2027. Additionally, The Biosimilars market is expected to witness highest CAGR of 39.6% during (2021 - 2027).

Based on Drug Class, the market is segmented into Biologics and Biosimilars. Based on Product, the market is segmented into Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa and others. Based on Application, the market is segmented into Renal Diseases, Cancer, Hematology and Neurology. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson and Johnson, Teva Pharmaceuticals Industries Ltd., Amgen, Inc., F. Hoffmann-La Roche Ltd., Biocon Limited, Intas Pharmaceutical Ltd., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., LG Corporation (LG Life Sciences Ltd.), and Celltrion, Inc.

Scope of the Study

Market Segments covered in the Report:

By Drug Class

  • Biologics
  • Biosimilars

By Product

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • others

By Application

  • Renal Diseases
  • Cancer
  • Hematology
  • Neurology

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

  • Johnson and Johnson
  • Teva Pharmaceuticals Industries Ltd.
  • Amgen, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocon Limited
  • Intas Pharmaceutical Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • LG Corporation (LG Life Sciences Ltd.)
  • Celltrion, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 LAMEA Erythropoietin Drugs Market, by Drug Class
    • 1.4.2 LAMEA Erythropoietin Drugs Market, by Product
    • 1.4.3 LAMEA Erythropoietin Drugs Market, by Application
    • 1.4.4 LAMEA Erythropoietin Drugs Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market composition and scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. LAMEA Erythropoietin Drugs Market by Drug Class

  • 3.1 LAMEA Biologics Market by Country
  • 3.2 LAMEA Biosimilars Market by Country

Chapter 4. LAMEA Erythropoietin Drugs Market by Product

  • 4.1 LAMEA Epoetin-alfa Market by Country
  • 4.2 LAMEA Epoetin-beta Market by Country
  • 4.3 LAMEA Darbepoetin-alfa Market by Country
  • 4.4 LAMEA Other Product Market by Country

Chapter 5. LAMEA Erythropoietin Drugs Market by Application

  • 5.1 LAMEA Renal Diseases Market by Country
  • 5.2 LAMEA Cancer Market by Country
  • 5.3 LAMEA Hematology Market by Country
  • 5.4 LAMEA Neurology Market by Country

Chapter 6. LAMEA Erythropoietin Drugs Market by Country

  • 6.1 Brazil Erythropoietin Drugs Market
    • 6.1.1 Brazil Erythropoietin Drugs Market by Drug Class
    • 6.1.2 Brazil Erythropoietin Drugs Market by Product
    • 6.1.3 Brazil Erythropoietin Drugs Market by Application
  • 6.2 Argentina Erythropoietin Drugs Market
    • 6.2.1 Argentina Erythropoietin Drugs Market by Drug Class
    • 6.2.2 Argentina Erythropoietin Drugs Market by Product
    • 6.2.3 Argentina Erythropoietin Drugs Market by Application
  • 6.3 UAE Erythropoietin Drugs Market
    • 6.3.1 UAE Erythropoietin Drugs Market by Drug Class
    • 6.3.2 UAE Erythropoietin Drugs Market by Product
    • 6.3.3 UAE Erythropoietin Drugs Market by Application
  • 6.4 Saudi Arabia Erythropoietin Drugs Market
    • 6.4.1 Saudi Arabia Erythropoietin Drugs Market by Drug Class
    • 6.4.2 Saudi Arabia Erythropoietin Drugs Market by Product
    • 6.4.3 Saudi Arabia Erythropoietin Drugs Market by Application
  • 6.5 South Africa Erythropoietin Drugs Market
    • 6.5.1 South Africa Erythropoietin Drugs Market by Drug Class
    • 6.5.2 South Africa Erythropoietin Drugs Market by Product
    • 6.5.3 South Africa Erythropoietin Drugs Market by Application
  • 6.6 Nigeria Erythropoietin Drugs Market
    • 6.6.1 Nigeria Erythropoietin Drugs Market by Drug Class
    • 6.6.2 Nigeria Erythropoietin Drugs Market by Product
    • 6.6.3 Nigeria Erythropoietin Drugs Market by Application
  • 6.7 Rest of LAMEA Erythropoietin Drugs Market
    • 6.7.1 Rest of LAMEA Erythropoietin Drugs Market by Drug Class
    • 6.7.2 Rest of LAMEA Erythropoietin Drugs Market by Product
    • 6.7.3 Rest of LAMEA Erythropoietin Drugs Market by Application

Chapter 7. Company Profiles

  • 7.1 Johnson and Johnson
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental &Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Approvals:
  • 7.2 Teva Pharmaceutical Industries Ltd.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Amgen, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.5 Recent strategies and developments:
      • 7.3.5.1 Partnerships, Collaborations, and Agreements:
  • 7.4 F. Hoffmann-La Roche Ltd.
    • 7.4.1 Company Overview
    • 7.4.1 Financial Analysis
    • 7.4.2 Segmental and Regional Analysis
    • 7.4.3 Research & Development Expense
  • 7.5 Biocon Limited
    • 7.5.1 Company Overview
  • 7.6 Intas Pharmaceutical Ltd.
    • 7.6.1 Company Overview
  • 7.7 Sun Pharmaceutical Industries Ltd.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Dr. Reddy's Laboratories Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 LG Corporation (LG Life Sciences Ltd.)
    • 7.9.1 Company Overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Segmental and Regional Analysis
  • 7.10. Celltrion, Inc.
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 2 LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 3 LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 4 LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 5 LAMEA Biologics Market by Country, 2017 - 2020, USD Million
  • TABLE 6 LAMEA Biologics Market by Country, 2021 - 2027, USD Million
  • TABLE 7 LAMEA Biosimilars Market by Country, 2017 - 2020, USD Million
  • TABLE 8 LAMEA Biosimilars Market by Country, 2021 - 2027, USD Million
  • TABLE 9 LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 10 LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 11 LAMEA Epoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 12 LAMEA Epoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 13 LAMEA Epoetin-beta Market by Country, 2017 - 2020, USD Million
  • TABLE 14 LAMEA Epoetin-beta Market by Country, 2021 - 2027, USD Million
  • TABLE 15 LAMEA Darbepoetin-alfa Market by Country, 2017 - 2020, USD Million
  • TABLE 16 LAMEA Darbepoetin-alfa Market by Country, 2021 - 2027, USD Million
  • TABLE 17 LAMEA Other Product Market by Country, 2017 - 2020, USD Million
  • TABLE 18 LAMEA Other Product Market by Country, 2021 - 2027, USD Million
  • TABLE 19 LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 20 LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 21 LAMEA Renal Diseases Market by Country, 2017 - 2020, USD Million
  • TABLE 22 LAMEA Renal Diseases Market by Country, 2021 - 2027, USD Million
  • TABLE 23 LAMEA Cancer Market by Country, 2017 - 2020, USD Million
  • TABLE 24 LAMEA Cancer Market by Country, 2021 - 2027, USD Million
  • TABLE 25 LAMEA Hematology Market by Country, 2017 - 2020, USD Million
  • TABLE 26 LAMEA Hematology Market by Country, 2021 - 2027, USD Million
  • TABLE 27 LAMEA Neurology Market by Country, 2017 - 2020, USD Million
  • TABLE 28 LAMEA Neurology Market by Country, 2021 - 2027, USD Million
  • TABLE 29 LAMEA Erythropoietin Drugs Market by Country, 2017 - 2020, USD Million
  • TABLE 30 LAMEA Erythropoietin Drugs Market by Country, 2021 - 2027, USD Million
  • TABLE 31 Brazil Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 32 Brazil Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 33 Brazil Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 34 Brazil Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 35 Brazil Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 36 Brazil Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 37 Brazil Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 38 Brazil Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 39 Argentina Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 40 Argentina Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 41 Argentina Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 42 Argentina Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 43 Argentina Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 44 Argentina Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 45 Argentina Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 46 Argentina Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 47 UAE Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 48 UAE Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 49 UAE Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 50 UAE Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 51 UAE Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 52 UAE Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 53 UAE Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 54 UAE Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 55 Saudi Arabia Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 56 Saudi Arabia Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 57 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 58 Saudi Arabia Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 59 Saudi Arabia Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 60 Saudi Arabia Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 61 Saudi Arabia Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 62 Saudi Arabia Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 63 South Africa Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 64 South Africa Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 65 South Africa Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 66 South Africa Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 67 South Africa Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 68 South Africa Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 69 South Africa Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 70 South Africa Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 71 Nigeria Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 72 Nigeria Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 73 Nigeria Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 74 Nigeria Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 75 Nigeria Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 76 Nigeria Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 77 Nigeria Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 78 Nigeria Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 79 Rest of LAMEA Erythropoietin Drugs Market, 2017 - 2020, USD Million
  • TABLE 80 Rest of LAMEA Erythropoietin Drugs Market, 2021 - 2027, USD Million
  • TABLE 81 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2017 - 2020, USD Million
  • TABLE 82 Rest of LAMEA Erythropoietin Drugs Market by Drug Class, 2021 - 2027, USD Million
  • TABLE 83 Rest of LAMEA Erythropoietin Drugs Market by Product, 2017 - 2020, USD Million
  • TABLE 84 Rest of LAMEA Erythropoietin Drugs Market by Product, 2021 - 2027, USD Million
  • TABLE 85 Rest of LAMEA Erythropoietin Drugs Market by Application, 2017 - 2020, USD Million
  • TABLE 86 Rest of LAMEA Erythropoietin Drugs Market by Application, 2021 - 2027, USD Million
  • TABLE 87 Key information -Johnson and Johnson
  • TABLE 88 Key Information - Teva Pharmaceuticals Industries Ltd.
  • TABLE 89 Key Information - Amgen, Inc.
  • TABLE 90 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 91 Key Information - Biocon Limited
  • TABLE 92 Key Information - Intas Pharmaceutical Ltd.
  • TABLE 93 Key Information - Sun Pharmaceutical Industries Ltd.
  • TABLE 94 key information - Dr. Reddy's Laboratories Ltd.
  • TABLE 95 Key Information - LG Corporation
  • TABLE 96 key information - Celltrion, Inc.

List of Figures

  • FIG 1 Methodology for the research